Leavell Investment Management Inc. Has $1.63 Million Position in Walgreens Boots Alliance, Inc. (WBA)
Leavell Investment Management Inc. trimmed its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 0.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 20,748 shares of the pharmacy operator’s stock after selling 36 shares during the quarter. Leavell Investment Management Inc.’s holdings in Walgreens Boots Alliance were worth $1,625,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Hudock Capital Group LLC increased its stake in shares of Walgreens Boots Alliance by 0.4% in the first quarter. Hudock Capital Group LLC now owns 1,300 shares of the pharmacy operator’s stock worth $108,000 after buying an additional 5 shares during the period. Tarbox Group Inc. increased its stake in shares of Walgreens Boots Alliance by 288.3% in the first quarter. Tarbox Group Inc. now owns 1,355 shares of the pharmacy operator’s stock worth $113,000 after buying an additional 1,006 shares during the period. Webster Bank N. A. increased its stake in shares of Walgreens Boots Alliance by 18.4% in the first quarter. Webster Bank N. A. now owns 1,509 shares of the pharmacy operator’s stock worth $125,000 after buying an additional 235 shares during the period. MCF Advisors LLC increased its stake in shares of Walgreens Boots Alliance by 68.2% in the first quarter. MCF Advisors LLC now owns 1,923 shares of the pharmacy operator’s stock worth $160,000 after buying an additional 780 shares during the period. Finally, Founders Capital Management purchased a new position in shares of Walgreens Boots Alliance in the first quarter worth $161,000. 60.16% of the stock is currently owned by institutional investors.
WARNING: This story was originally posted by Watch List News and is the property of of Watch List News. If you are viewing this story on another domain, it was illegally stolen and republished in violation of United States and international trademark & copyright law. The correct version of this story can be viewed at https://www.watchlistnews.com/leavell-investment-management-inc-has-1-63-million-position-in-walgreens-boots-alliance-inc-wba/1587426.html.
In other news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction on Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total transaction of $218,305.44. Following the transaction, the director now owns 19,151 shares in the company, valued at $1,528,058.29. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 13.50% of the company’s stock.
Several brokerages recently commented on WBA. Needham & Company LLC set a $94.00 target price on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Monday, July 17th. Pivotal Research set a $85.00 target price on shares of Walgreens Boots Alliance and gave the stock a “hold” rating in a research note on Sunday, July 2nd. Guggenheim reaffirmed a “buy” rating on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. Goldman Sachs Group, Inc. (The) reaffirmed a “neutral” rating and issued a $77.00 target price (down from $89.00) on shares of Walgreens Boots Alliance in a research note on Wednesday, June 28th. Finally, Morgan Stanley reaffirmed an “overweight” rating and issued a $95.00 target price on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and fifteen have given a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $92.06.
Walgreens Boots Alliance, Inc. (NASDAQ WBA) traded up 0.83% during mid-day trading on Monday, hitting $79.06. 2,398,485 shares of the stock were exchanged. The stock has a 50 day moving average of $81.36 and a 200-day moving average of $81.86. The stock has a market cap of $84.60 billion, a price-to-earnings ratio of 19.96 and a beta of 1.26. Walgreens Boots Alliance, Inc. has a 52-week low of $75.18 and a 52-week high of $89.69.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, beating the consensus estimate of $1.30 by $0.03. The firm had revenue of $30.12 billion for the quarter, compared to analyst estimates of $29.72 billion. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. The business’s revenue for the quarter was up 2.1% on a year-over-year basis. During the same quarter last year, the firm posted $1.18 earnings per share. Equities analysts predict that Walgreens Boots Alliance, Inc. will post $5.00 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Tuesday, September 12th. Stockholders of record on Friday, August 18th were paid a dividend of $0.40 per share. The ex-dividend date of this dividend was Wednesday, August 16th. This represents a $1.60 annualized dividend and a dividend yield of 2.04%. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 40.30%.
Walgreens Boots Alliance declared that its Board of Directors has approved a stock repurchase plan on Thursday, June 29th that permits the company to buyback $5.00 billion in outstanding shares. This buyback authorization permits the pharmacy operator to reacquire up to 5.9% of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s management believes its stock is undervalued.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.